SG Americas Securities, LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 221 filers reported holding BRIDGEBIO PHARMA INC in Q1 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$123
-62.0%
4,656
-76.2%
0.00%
-75.0%
Q1 2023$324
-99.8%
19,545
-8.3%
0.00%
+33.3%
Q3 2022$212,000
-80.9%
21,316
-82.6%
0.00%
-75.0%
Q2 2022$1,111,000
+263.1%
122,311
+305.9%
0.01%
+500.0%
Q1 2022$306,000
+29.1%
30,134
+112.3%
0.00%
+100.0%
Q4 2021$237,000
-80.1%
14,195
-44.0%
0.00%
-83.3%
Q3 2021$1,188,000
+4.3%
25,337
+35.6%
0.01%
+20.0%
Q2 2021$1,139,000
+27.5%
18,680
+28.9%
0.01%0.0%
Q1 2021$893,000
-32.2%
14,495
-21.8%
0.01%
-28.6%
Q4 2020$1,318,000
+131.6%
18,532
+22.3%
0.01%
+75.0%
Q3 2020$569,000
-13.7%
15,158
-25.0%
0.00%
-20.0%
Q2 2020$659,000
+53.6%
20,198
+36.5%
0.01%
+25.0%
Q1 2020$429,000
+123.4%
14,792
+170.0%
0.00%
+100.0%
Q4 2019$192,000
-59.7%
5,478
-69.0%
0.00%
-33.3%
Q2 2019$476,00017,6470.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 3,835,722$82,353,00042.93%
Kohlberg Kravis Roberts & Co. L.P. 36,900,661$792,257,0004.46%
Perceptive Advisors 6,706,268$143,983,0003.88%
Cormorant Asset Management, LP 2,617,566$56,199,0003.42%
VIKING GLOBAL INVESTORS LP 26,620,991$571,553,0002.98%
SC US (TTGP), LTD. 2,544,738$54,636,0002.42%
HHLR ADVISORS, LTD. 4,388,690$94,225,0001.30%
Fernwood Investment Management, LLC 95,200$2,044,0001.01%
AMERICAN INTERNATIONAL GROUP, INC. 6,746,511$144,847,0000.58%
Ratan Capital Management LP 46,548$999,0000.53%
View complete list of BRIDGEBIO PHARMA INC shareholders